146 related articles for article (PubMed ID: 22183996)
1. [A safety study of retinal toxicity after serial intravitreal injections of infliximab in rabbits eyes].
Rassi AR; Rigueiro MP; Isaac DL; Dourado L; Abud MB; Freitas EC; Carneiro LB; Avila MP
Arq Bras Oftalmol; 2011; 74(5):352-6. PubMed ID: 22183996
[TBL] [Abstract][Full Text] [Related]
2. A pilot study on ocular safety of intravitreal infliximab in a rabbit model.
Giansanti F; Ramazzotti M; Vannozzi L; Rapizzi E; Fiore T; Iaccheri B; Degl' Innocenti D; Moncini D; Menchini U
Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1151-6. PubMed ID: 18326743
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal administration of the anti-TNF monoclonal antibody infliximab in the rabbit.
Theodossiadis PG; Liarakos VS; Sfikakis PP; Charonis A; Agrogiannis G; Kavantzas N; Vergados IA
Graefes Arch Clin Exp Ophthalmol; 2009 Feb; 247(2):273-81. PubMed ID: 18982345
[TBL] [Abstract][Full Text] [Related]
4. Infliximab exerts a dose-dependent effect on retinal safety in the albino rabbit.
Zayit-Soudry S; Vainer I; Zemel E; Mimouni M; Rabena M; Pieramici DJ; Perlman I; Loewenstein A
Doc Ophthalmol; 2017 Dec; 135(3):175-185. PubMed ID: 28825191
[TBL] [Abstract][Full Text] [Related]
5. Ocular toxicity of intravitreous adalimumab (Humira) in the rabbit.
Manzano RP; Peyman GA; Carvounis PE; Kivilcim M; Khan P; Chevez-Barrios P; Takahashi W
Graefes Arch Clin Exp Ophthalmol; 2008 Jun; 246(6):907-11. PubMed ID: 18414888
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of vitreous clearance and potential retinal toxicity of intravitreal lornoxicam (xefo).
Diakonis VF; Tsourdou A; Tzatzarakis MN; Tsika C; Charisis S; Naoumidi I; Plainis S; Tsilimbaris MK
J Ocul Pharmacol Ther; 2013 Sep; 29(7):627-32. PubMed ID: 23556534
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal toxicity of garenoxacin.
Esfahani MR; Kazi AA; Peyman GA; Dellacroce JT; Aydin E
Retina; 2006 Feb; 26(2):182-6. PubMed ID: 16467675
[TBL] [Abstract][Full Text] [Related]
8. Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma.
Buitrago E; Del Sole MJ; Torbidoni A; Fandino A; Asprea M; Croxatto JO; Chantada GL; Bramuglia GF; Schaiquevich P
Exp Eye Res; 2013 Mar; 108():103-9. PubMed ID: 23333535
[TBL] [Abstract][Full Text] [Related]
9. [Retinal toxicity of intravitreal doxycycline. A pilot study].
Aydin E; Kazi AA; Peyman GA; Esfahani MR; Muñoz-Morales A; Kivilcim M; Caro-Magdaleno M
Arch Soc Esp Oftalmol; 2007 Apr; 82(4):223-8. PubMed ID: 17443427
[TBL] [Abstract][Full Text] [Related]
10. Safety of repeated intravitreous injections of antibiotics and dexamethasone.
Yoshizumi MO; Bhavsar AR; Dessouki A; Kashani A
Retina; 1999; 19(5):437-41. PubMed ID: 10546941
[TBL] [Abstract][Full Text] [Related]
11. intravitreal tumor necrosis factor inhibitors in the treatment of refractory diabetic macular edema: a pilot study from the Pan-American Collaborative Retina Study Group.
Wu L; Hernandez-Bogantes E; Roca JA; Arevalo JF; Barraza K; Lasave AF
Retina; 2011 Feb; 31(2):298-303. PubMed ID: 21099452
[TBL] [Abstract][Full Text] [Related]
12. Retinal toxicity of intravitreal trastuzumab in a rabbit model: preliminary results of an experimental study.
Moschos MM; Chatziralli IP; Kalogeropoulos C; Georgountzos V; Agapitos E
J Ocul Pharmacol Ther; 2013 Oct; 29(8):754-9. PubMed ID: 23597072
[TBL] [Abstract][Full Text] [Related]
13. Adverse events after intravitreal infliximab (Remicade).
Giganti M; Beer PM; Lemanski N; Hartman C; Schartman J; Falk N
Retina; 2010 Jan; 30(1):71-80. PubMed ID: 19996827
[TBL] [Abstract][Full Text] [Related]
14. Toxicity of high-dose intravitreal adalimumab (Humira) in the rabbit.
Manzano RP; Peyman GA; Carvounis PE; Damico FM; Aguiar RG; Ioshimoto GL; Ventura DF; Cursino ST; Takahashi W
J Ocul Pharmacol Ther; 2011 Aug; 27(4):327-31. PubMed ID: 21668348
[TBL] [Abstract][Full Text] [Related]
15. Reliability of intravitreal nepafenac in rabbits.
Afrashi F; Hashas AS; Shahbazov C; Arici M; Yikilmaz MS; Deveci R; Karacali S; Sahar U
J Ocul Pharmacol Ther; 2015 Feb; 31(1):43-50. PubMed ID: 25285465
[TBL] [Abstract][Full Text] [Related]
16. Retinal toxicity of intravitreal tenecteplase in the rabbit.
Rowley SA; Vijayasekaran S; Yu PK; McAllister IL; Yu DY
Br J Ophthalmol; 2004 Apr; 88(4):573-8. PubMed ID: 15031179
[TBL] [Abstract][Full Text] [Related]
17. Safety of intravitreal injection of bevacizumab in rabbit eyes.
Feiner L; Barr EE; Shui YB; Holekamp NM; Brantley MA
Retina; 2006 Oct; 26(8):882-8. PubMed ID: 17031287
[TBL] [Abstract][Full Text] [Related]
18. Safety of intravitreal clindamycin in albino rabbit eyes.
Habot-Wilner Z; Mazza O; Shahar J; Massarweh A; Mann I; Loewenstein A; Perlman I
Doc Ophthalmol; 2017 Oct; 135(2):133-146. PubMed ID: 28744691
[TBL] [Abstract][Full Text] [Related]
19. Determination of nontoxic concentrations of piperacillin/tazobactam for intravitreal application. An electroretinographic, histopathologic and morphometric analysis.
Ozkiriş A; Evereklioglu C; Kontaş O; Oner AO; Erkiliç K
Ophthalmic Res; 2004; 36(3):139-44. PubMed ID: 15103204
[TBL] [Abstract][Full Text] [Related]
20. Ocular toxicity of intravitreal tacrolimus.
Passos E; Genaidy MM; Peyman GA
Ophthalmic Surg Lasers; 2002; 33(2):140-4. PubMed ID: 11942546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]